This compound is primarily utilized in organic synthesis, particularly in cross-coupling reactions like Suzuki-Miyaura coupling, due to the presence of the boronate ester group. Its structure makes it a valuable intermediate in the development of pharmaceuticals, especially in the synthesis of complex molecules targeting central nervous system disorders. The piperazine moiety enhances its potential as a building block for drug candidates with improved bioavailability and binding affinity. Additionally, its chiral nature allows for the creation of enantiomerically pure compounds, which is crucial in the development of drugs with specific stereochemical requirements.